1,720,961 research outputs found
Video abstract for publication: Managing pain and inflammation associated with musculoskeletal disease: time for a change?
No full textIn this 18-min video interview Prof. Alberto Migliore discusses current trends in pain management and expands on inflammation resolution. Prof. Migliore is a co-author of the same-title peer-reviewed opinion article published in the journal Current Medical Research and Opinion in 2022.</p
sj-docx-2-tab-10.1177_1759720X211002682 – Supplemental material for Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis
No full textSupplemental material, sj-docx-2-tab-10.1177_1759720X211002682 for Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis by Alberto Migliore, Giuseppe Pompilio, Davide Integlia, Joe Zhuo and Evo Alemao in Therapeutic Advances in Musculoskeletal Disease</p
sj-docx-1-tab-10.1177_1759720X211002682 – Supplemental material for Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis
No full textSupplemental material, sj-docx-1-tab-10.1177_1759720X211002682 for Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis by Alberto Migliore, Giuseppe Pompilio, Davide Integlia, Joe Zhuo and Evo Alemao in Therapeutic Advances in Musculoskeletal Disease</p
sj-docx-5-tab-10.1177_1759720X211002682 – Supplemental material for Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis
No full textSupplemental material, sj-docx-5-tab-10.1177_1759720X211002682 for Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis by Alberto Migliore, Giuseppe Pompilio, Davide Integlia, Joe Zhuo and Evo Alemao in Therapeutic Advances in Musculoskeletal Disease</p
sj-docx-4-tab-10.1177_1759720X211002682 – Supplemental material for Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis
No full textSupplemental material, sj-docx-4-tab-10.1177_1759720X211002682 for Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis by Alberto Migliore, Giuseppe Pompilio, Davide Integlia, Joe Zhuo and Evo Alemao in Therapeutic Advances in Musculoskeletal Disease</p
sj-docx-3-tab-10.1177_1759720X211002682 – Supplemental material for Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis
No full textSupplemental material, sj-docx-3-tab-10.1177_1759720X211002682 for Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis by Alberto Migliore, Giuseppe Pompilio, Davide Integlia, Joe Zhuo and Evo Alemao in Therapeutic Advances in Musculoskeletal Disease</p
sj-docx-6-tab-10.1177_1759720X211002682 – Supplemental material for Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis
No full textSupplemental material, sj-docx-6-tab-10.1177_1759720X211002682 for Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis by Alberto Migliore, Giuseppe Pompilio, Davide Integlia, Joe Zhuo and Evo Alemao in Therapeutic Advances in Musculoskeletal Disease</p
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
Full text link“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
- …
